Approvals (Drugs@FDA)

RIFAPENTINE

MACLEODS PHARMS · RIFAPENTINE

ANDA217042Generic (ANDA)Prescription
Open FDA's page for this record
Application number
ANDA217042
Sponsor name
MACLEODS PHARMS
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20260623
    Review priority
    STANDARD
    Submission class code
    UNKNOWN
Products
  1. Product number
    001
    Reference drug
    No
    Brand name
    RIFAPENTINE
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      RIFAPENTINE
      Strength
      150MG
Harmonized identifiers (openFDA)
Application number
ANDA217042
Brand name
RIFAPENTINE
Generic name
RIFAPENTINE
Manufacturer name
Macleods Pharmaceuticals Limited
Product NDC
33342-599
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
RIFAPENTINE
RxCUI
242671
SPL ID
f95d726e-5a09-48dd-b719-e4400fb91c8f
SPL set ID
f95d726e-5a09-48dd-b719-e4400fb91c8f
Package NDC
33342-599-20, 33342-599-54
Nui
N0000175501, M0019113
Pharm class epc
Rifamycin Antimycobacterial [EPC]
Pharm class cs
Rifamycins [CS]
UNII
XJM390A33U
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.